Vor Biopharma Inc
VORHealthcare|Biotechnology|USA
$19.14
-0.61 (-3.09%)
Earnings Power
$10.66
Upcoming Data Readouts (2)
May 2027
Est. completion
P3Generalized Myasthenia Gravis
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
NCT06456580n=180
Dec 2028
Est. completion
P3Primary Sjogren's Disease
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
NCT07404865n=250